SpyGlass Pharma has acquired Advanced Vision Science for approximately $13 million, bringing manufacturing of a key intraocular lens used in its drug-delivery platform in-house.

The agreement expands Lupin's European ophthalmology portfolio by adding the first once-daily dual-agent eye drop approved for presbyopia while strengthening its specialty eye care strategy.

New analysis of physician payment data places ophthalmology among Canada's highest-billing specialties, with median gross billings reaching C$1.18 million in British Columbia.

The Medscape Ophthalmologist Compensation Report 2026 shows ophthalmology remains one of the highest-paying physician specialties